We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
Home
Services
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Team
Our knowledge, expertise & publications
View all
Deals & Cases
Careers
Vifor Pharma acquires Zurich-based Inositec AG. Inositec develops first-in-class non-dialysis treatments for soft tissue and vascular calcification disorders.
RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF) ("Relief"), a biopharmaceutical company, has launched its Level 1 American Depositary Receipt ("ADR") program in the United States. As of 18 November 2021, ADRs may be traded over the counter.
GlycoEra AG has closed CHF 45m (USD 49m) Series A financing round, co-led by renowned US and European life science investors, 5AM Ventures, Roche Venture Fund and Sofinnova Partners.
VISCHER successfully represented a Swiss bank in a multi-million dispute revolving around a fiduciary investment. The foreign bank had gone bankrupt.
MiniNaviDent has received an investment by Straumann Holding AG to further develop and market its DENACAM system, a miniaturized dynamic navigation system for dental implants. Furthermore, the company has simultaneously entered...
The full-service PR and communications agency cR Kommunikation AG with offices in Bern, Basel and Zurich has joined the MYTY Group, a leading agency network in the DACH region.
Bachem Holding AG (SIX:BANB) has raised CHF 583.5m through an accelerated bookbuilding process by issuing 750,000 new shares at a placement price of CHF 778 per share. Bachem is a leading, innovation-driven company specializing in...
Nautilus, Inc., an innovation leader in home fitness, has acquired Zurich based VAY AG, a leader in motion detection and analysis.
A fund advised by AFINUM Management AG signed on 8 October 2021 a share purchase agreement with exceet Group AG, a company of the exceet Group, to buy exceet Group's portfolio company GS Swiss PCB AG.
STOCKHOLM - CombiGene AB and Spark Therapeutics announced the signing of an exclusive collaboration and licensing agreement for CombiGene’s CG01 project.
Displaying results 1 to 10 out of 401
